Saturday 14 November 2026 Daily emailMarket analysisEnterpriseVigiEye regulatory newsCompePharma CRM & HR →
The business of pharma
Manufacturing & supply

Hettich centrifuge recall in Canada leaves cost and remedy questions unanswered

Health Canada has posted a recall of Hettich's ROTOFIX 32A bench centrifuge over a closure fault, but the notice gives no remedy, timeline or financial detail.

06 Nov 2026 · Health Canada · Regulator

Health Canada has listed a recall of the ROTOFIX 32A centrifuge from Andreas Hettich GmbH, of Tuttlingen, Germany. The notice was posted on 6 November 2026 under reference RA-82924 and gives 20 October 2026 as the recall date.

The regulator says the locking mechanism on certain units may not always close firmly. In that case the handle bar or latch could be left open while the instrument is spinning. It files the matter as a device performance problem under chemistry devices, and names healthcare users as the audience.

The commercial consequences are not set out. The notice names one model or catalogue number, HET-120601, but says the affected lot or serial numbers exceed ten and does not list them. Users are told only to contact Hettich, so the number of units in Canada is unknown. The source also gives no repair, replacement or refund plan, and no cost or sales figures.

It does not mention any injuries or incidents. As general context, Canada's Type II category covers products that may cause temporary or medically reversible health effects, or where serious harm is considered unlikely.

Why it matters

  • Exposure is unquantified: the notice lists no serial numbers and no unit count, so the scale of the recall in Canada cannot be gauged from public information.
  • The manufacturer's remedy is not disclosed, so any servicing, replacement or cost implications for Hettich, distributors and laboratories remain unknown.
  • Laboratories running catalogue number HET-120601 must obtain serial-level information directly from Hettich, since the regulator's notice does not provide it.
  • Quality and regulatory teams have a specific failure mode, an incompletely secured lid during operation, to weigh in equipment risk reviews.

Official record: Health Canada ↗

Written by CompePharma's editorial system from the official record. AI-assisted; check the source before acting. Not investment advice.

More Manufacturing & supplyAll →